EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
lymphocyte |
isoform 11betaHSD2 |
741066 |
1.1.1.205 | IMP dehydrogenase |
lymphocyte |
- |
347951, 667980, 670881, 703271, 705494, 706090 |
1.1.1.205 | IMP dehydrogenase |
lymphocyte |
peripheral blood lymphocytes |
667937 |
1.1.1.205 | IMP dehydrogenase |
lymphocyte |
type I isoform is prevalent |
705494 |
1.1.1.211 | long-chain-3-hydroxyacyl-CoA dehydrogenase |
lymphocyte |
- |
761165 |
1.1.1.34 | hydroxymethylglutaryl-CoA reductase (NADPH) |
lymphocyte |
- |
286571 |
1.1.1.44 | phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) |
lymphocyte |
from spleen, lymph node or thymus |
760842 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
lymphocyte |
- |
686263 |
1.1.99.2 | L-2-hydroxyglutarate dehydrogenase |
lymphocyte |
- |
699377 |
1.13.11.33 | arachidonate 15-lipoxygenase |
lymphocyte |
- |
639264 |
1.13.11.52 | indoleamine 2,3-dioxygenase |
lymphocyte |
- |
712647, 713586, 725120, 742634 |
1.14.13.39 | nitric-oxide synthase (NADPH) |
lymphocyte |
constitutive expression of full length nitric oxide synthase isoforms. Lymphocytes express more inducible nitric oxide synthase transcripts and protein than neuronal nitric oxide synthase and endothelial nitric oxide synthase |
724425 |
1.14.16.2 | tyrosine 3-monooxygenase |
lymphocyte |
- |
745111 |
1.14.18.2 | CMP-N-acetylneuraminate monooxygenase |
lymphocyte |
from thymus, spleen, lymph node and peripheral blood. Highest activity in peripheral blood lymphocytes |
639330 |
1.16.3.1 | ferroxidase |
lymphocyte |
nonadherent cells, T and B lymphocytes |
438021 |
1.17.3.2 | xanthine oxidase |
lymphocyte |
- |
675050 |
1.17.4.4 | vitamin-K-epoxide reductase (warfarin-sensitive) |
lymphocyte |
B lymphocyte, measurement of allelic mRNA expression |
685791 |
1.2.1.3 | aldehyde dehydrogenase (NAD+) |
lymphocyte |
- |
697280 |
1.2.4.2 | oxoglutarate dehydrogenase (succinyl-transferring) |
lymphocyte |
- |
740535 |
1.3.1.24 | biliverdin reductase |
lymphocyte |
- |
740486 |
1.3.3.3 | coproporphyrinogen oxidase |
lymphocyte |
- |
390945, 684418 |
1.3.3.4 | protoporphyrinogen oxidase |
lymphocyte |
from healthy women and porphyria (VP) patient women, enzyme PPOX activity is reduced in the latter |
744837 |
1.3.5.1 | succinate dehydrogenase |
lymphocyte |
from newborn and adult rats both in hyperadrenergic status, the activity in newborn rats is 3-8fold higher than in adult rats |
685306 |
1.3.8.1 | short-chain acyl-CoA dehydrogenase |
lymphocyte |
- |
712126 |
1.3.8.4 | isovaleryl-CoA dehydrogenase |
lymphocyte |
- |
655248, 689020 |
1.3.8.7 | medium-chain acyl-CoA dehydrogenase |
lymphocyte |
- |
688185, 690129 |
1.3.8.8 | long-chain acyl-CoA dehydrogenase |
lymphocyte |
- |
689340, 700905 |
1.3.8.9 | very-long-chain acyl-CoA dehydrogenase |
lymphocyte |
- |
689340, 763406 |
1.3.98.1 | dihydroorotate dehydrogenase (fumarate) |
lymphocyte |
cell line A20R generated by gradually exposing A20N cells to increasing concentrations of enzyme inhibitor leflunomide |
656884 |
1.4.3.13 | protein-lysine 6-oxidase |
lymphocyte |
- |
689104 |
1.4.3.4 | monoamine oxidase |
lymphocyte |
MAO B is the only isoform in platelets and lymphocytes |
684241 |
1.4.3.4 | monoamine oxidase |
lymphocyte |
predominantly B form |
394572 |
1.5.1.15 | methylenetetrahydrofolate dehydrogenase (NAD+) |
lymphocyte |
- |
392077 |
1.5.1.20 | methylenetetrahydrofolate reductase [NAD(P)H] |
lymphocyte |
- |
437721, 654163, 686572, 686592, 688688 |
1.5.1.34 | 6,7-dihydropteridine reductase |
lymphocyte |
- |
656444 |
1.5.99.B2 | proline dehydrogenase (acceptor) |
lymphocyte |
- |
689987 |
1.6.3.1 | NAD(P)H oxidase (H2O2-forming) |
lymphocyte |
peripheral blood lymphocyte |
685992 |
1.6.5.2 | NAD(P)H dehydrogenase (quinone) |
lymphocyte |
no correlation between NQO1 activity in rectal biopsies and NQO1 activity in total lymphocytes. No correlation between total leukocyte and lymphocyte NQO1 activity |
689279 |
1.8.5.1 | glutathione dehydrogenase (ascorbate) |
lymphocyte |
- |
394019 |
2.1.1.13 | methionine synthase |
lymphocyte |
- |
441195, 441196 |
2.1.1.2 | guanidinoacetate N-methyltransferase |
lymphocyte |
- |
757529 |
2.1.1.6 | catechol O-methyltransferase |
lymphocyte |
no effect of sex on COMT activity |
657507 |
2.1.1.63 | methylated-DNA-[protein]-cysteine S-methyltransferase |
lymphocyte |
- |
701644 |
2.1.1.67 | thiopurine S-methyltransferase |
lymphocyte |
- |
485516, 485519, 485520, 485523, 485524, 686275 |
2.1.2.3 | phosphoribosylaminoimidazolecarboxamide formyltransferase |
lymphocyte |
- |
485750 |
2.1.4.1 | glycine amidinotransferase |
lymphocyte |
- |
485967, 661505 |
2.3.1.148 | glycerophospholipid acyltransferase (CoA-dependent) |
lymphocyte |
- |
16278 |
2.3.1.21 | carnitine O-palmitoyltransferase |
lymphocyte |
- |
659899 |
2.3.1.48 | histone acetyltransferase |
lymphocyte |
- |
487083 |
2.3.1.5 | arylamine N-acetyltransferase |
lymphocyte |
- |
686618, 755743 |
2.3.1.50 | serine C-palmitoyltransferase |
lymphocyte |
from patients with hereditary sensory neuropathy type I |
658205 |
2.3.1.6 | choline O-acetyltransferase |
lymphocyte |
- |
705279 |
2.3.1.97 | glycylpeptide N-tetradecanoyltransferase |
lymphocyte |
- |
487771 |
2.4.1.175 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase |
lymphocyte |
- |
736890 |
2.4.1.214 | glycoprotein 3-alpha-L-fucosyltransferase |
lymphocyte |
- |
662265 |
2.4.1.226 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase |
lymphocyte |
- |
736890 |
2.4.1.255 | protein O-GlcNAc transferase |
lymphocyte |
- |
703439 |
2.4.1.66 | procollagen glucosyltransferase |
lymphocyte |
- |
636786 |
2.4.2.1 | purine-nucleoside phosphorylase |
lymphocyte |
- |
703162 |
2.4.2.12 | nicotinamide phosphoribosyltransferase |
lymphocyte |
- |
489743, 722560, 736227 |
2.4.2.28 | S-methyl-5'-thioadenosine phosphorylase |
lymphocyte |
peripheral blood |
637535 |
2.4.2.3 | uridine phosphorylase |
lymphocyte |
peripheral |
658264 |
2.4.2.3 | uridine phosphorylase |
lymphocyte |
peripheral, very low activity |
658264 |
2.4.2.31 | NAD+-protein-arginine ADP-ribosyltransferase |
lymphocyte |
- |
638124 |
2.4.2.4 | thymidine phosphorylase |
lymphocyte |
- |
705495 |
2.4.2.8 | hypoxanthine phosphoribosyltransferase |
lymphocyte |
from peripheral blood |
703792 |
2.4.2.8 | hypoxanthine phosphoribosyltransferase |
lymphocyte |
G0 peripheral blood lymphocytes |
677077 |
2.4.2.8 | hypoxanthine phosphoribosyltransferase |
lymphocyte |
immature |
675050 |
2.4.3.3 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase |
lymphocyte |
sialylated histo-blood group carbohydrate CD175 is present in all hematopoietic cell lines and native lymphocytes examined. CD175 and sialylated CD175 are preferentially expressed on erythroblastic leukemia cell lines. Presence of sialylated CD175 is consistent with the expression of the gene encoding alpha2,6-sialyltransferase ST6GalNAc-1 |
687151 |
2.4.3.4 | beta-galactoside alpha-2,3-sialyltransferase |
lymphocyte |
T-lymphocytes, Epstein-Barr virus immortalized B-lymphocytes |
745255 |
2.4.3.6 | N-acetyllactosaminide alpha-2,3-sialyltransferase |
lymphocyte |
from peripheral blood mononuclear cells, enzyme level stimulated by phytohemagglutinin |
744288 |
2.4.3.9 | lactosylceramide alpha-2,3-sialyltransferase |
lymphocyte |
- |
721691 |
2.4.3.9 | lactosylceramide alpha-2,3-sialyltransferase |
lymphocyte |
from peripheral blood mononuclear cells, enzyme level is stimulated by growth in the presence of phytohemagglutinin |
636877 |
2.4.99.18 | dolichyl-diphosphooligosaccharide-protein glycotransferase |
lymphocyte |
- |
488511 |
2.5.1.6 | methionine adenosyltransferase |
lymphocyte |
- |
639060 |
2.5.1.6 | methionine adenosyltransferase |
lymphocyte |
from chronic leukemia cells |
639052 |
2.6.1.13 | ornithine aminotransferase |
lymphocyte |
- |
637129 |
2.6.1.42 | branched-chain-amino-acid transaminase |
lymphocyte |
- |
758657 |
2.7.1.1 | hexokinase |
lymphocyte |
contains mainly hexokinase I and a minor amount of hexokinase III in the soluble fraction, less than 10% |
640245 |
2.7.1.1 | hexokinase |
lymphocyte |
hexokinase type III |
640261 |
2.7.1.107 | diacylglycerol kinase (ATP) |
lymphocyte |
- |
640374, 640388 |
2.7.1.113 | deoxyguanosine kinase |
lymphocyte |
- |
661040 |
2.7.1.137 | phosphatidylinositol 3-kinase |
lymphocyte |
- |
640876 |
2.7.1.153 | phosphatidylinositol-4,5-bisphosphate 3-kinase |
lymphocyte |
high expression |
640876 |
2.7.1.20 | adenosine kinase |
lymphocyte |
adult |
641099 |
2.7.1.21 | thymidine kinase |
lymphocyte |
- |
661637 |
2.7.1.21 | thymidine kinase |
lymphocyte |
healthy and leucemic cells |
641158 |
2.7.1.3 | ketohexokinase |
lymphocyte |
relatively high expression of ketohexokinase.The expression profile for ketohexokinase in human is derived from from Unigene by adding the number of EST clones obtained from normal tissues |
678985 |
2.7.1.40 | pyruvate kinase |
lymphocyte |
- |
721787 |
2.7.1.67 | 1-phosphatidylinositol 4-kinase |
lymphocyte |
spleen |
641807, 641820 |
2.7.1.67 | 1-phosphatidylinositol 4-kinase |
lymphocyte |
type II enzyme |
641807 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
- |
641957, 641969, 641973, 661040 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
B-cell chronic lymphocytic leukaemia lymphocyte |
672894 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
from human leukemia patients |
641945 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
leukemic |
723303 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
normal cells and various leukemic cell lines |
641968 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
normal, acute myeloid leukemic and HL60 promyelocytic cells |
641954 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
tonsillar |
660812 |
2.7.1.74 | deoxycytidine kinase |
lymphocyte |
tonsillar lymphocyte |
641956, 641971 |
2.7.1.76 | 2'-deoxyadenosine kinase |
lymphocyte |
peripheral from adult |
641099 |